Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aliskiren induced remarkable hypertriglyceridemia.
Azushima K, Tamura K, Wakui H, Maeda A, Kanaoka T, Ohsawa M, Haku S, Uneda K, Toya Y, Umemura S. Azushima K, et al. Among authors: maeda a. Intern Med. 2012;51(24):3387-9. doi: 10.2169/internalmedicine.51.8567. Epub 2012 Dec 15. Intern Med. 2012. PMID: 23257525 Free article.
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.
Kanaoka T, Tamura K, Ohsawa M, Wakui H, Maeda A, Dejima T, Azushima K, Haku S, Mitsuhashi H, Yanagi M, Oshikawa J, Uneda K, Aoki K, Fujikawa T, Toya Y, Uchino K, Umemura S. Kanaoka T, et al. Among authors: maeda a. J Clin Hypertens (Greenwich). 2012 Aug;14(8):522-9. doi: 10.1111/j.1751-7176.2012.00640.x. Epub 2012 May 3. J Clin Hypertens (Greenwich). 2012. PMID: 22863160 Free PMC article. Clinical Trial.
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S. Ohsawa M, et al. Among authors: maeda a. Int J Mol Sci. 2013 Jul 24;14(8):15361-75. doi: 10.3390/ijms140815361. Int J Mol Sci. 2013. PMID: 23887656 Free PMC article. Clinical Trial.
Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S. Maeda A, et al. Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9. Clin Exp Hypertens. 2012. PMID: 22571446 Clinical Trial.
Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease.
Kanaoka T, Tamura K, Ohsawa M, Yanagi M, Haku S, Wakui H, Maeda A, Dejima T, Azushima K, Mitsuhashi H, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S. Kanaoka T, et al. Among authors: maeda a. Clin Exp Hypertens. 2012;34(4):264-9. doi: 10.3109/10641963.2012.681082. Epub 2012 May 11. Clin Exp Hypertens. 2012. PMID: 22578052
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
Kanaoka T, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Fujikawa T, Tsurumi-Ikeya Y, Maeda A, Yanagi M, Toya Y, Umemura S. Kanaoka T, et al. Among authors: maeda a. Int J Mol Sci. 2013 Aug 16;14(8):16866-81. doi: 10.3390/ijms140816866. Int J Mol Sci. 2013. PMID: 23959116 Free PMC article. Clinical Trial.
Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity.
Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S. Azushima K, et al. Among authors: maeda a. PLoS One. 2013 Oct 9;8(10):e75560. doi: 10.1371/journal.pone.0075560. eCollection 2013. PLoS One. 2013. PMID: 24130717 Free PMC article.
Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Ohsawa M, Tamura K, Wakui H, Maeda A, Dejima T, Kanaoka T, Azushima K, Uneda K, Tsurumi-Ikeya Y, Kobayashi R, Matsuda M, Uchida S, Toya Y, Kobori H, Nishiyama A, Yamashita A, Ishikawa Y, Umemura S. Ohsawa M, et al. Among authors: maeda a. Kidney Int. 2014 Sep;86(3):570-81. doi: 10.1038/ki.2014.95. Epub 2014 Apr 2. Kidney Int. 2014. PMID: 24694992 Free PMC article.
1,660 results